Clinical Trials Browser

Recurrence, Endometrial Neoplasms

Multiple Myeloma, Recurrence

Recurrence, Lymphoma, Large B-Cell, Diffuse

Burkitt Lymphoma, Leukemia, Hairy Cell, Waldenstrom Macroglobulinemia, Recurrence

Recurrence, Lymphoma, Mantle-Cell

Carcinoma, Non-Small-Cell Lung, Recurrence

Recurrence, Triple Negative Breast Neoplasms

Multiple Myeloma, Recurrence

Recurrence, Lymphoma, Mantle-Cell

Multiple Myeloma, Recurrence

Leukemia, Hairy Cell, Lymphoma, Non-Hodgkin, Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

Neoplasms, Recurrence

Melanoma, Recurrence

Recurrence, Neuroendocrine Tumors

Lymphoma, Recurrence

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Recurrence

Neoplasms, Recurrence, Lymphoma, B-Cell, Marginal Zone

Ependymoma, Medulloblastoma, Recurrence

Multiple Myeloma, Recurrence

Recurrence, Leukemia, Myeloid, Acute

Ependymoma, Glioma, Recurrence

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

Recurrence, Lymphoma, B-Cell

Clinical Trials

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

ELISA in Relapsed/Refractory MM

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

ZUMA-25

Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma

Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC

EPPIL

LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

KarMMa-2

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)

Entinostat Neuroendocrine (NE) Tumor

EXPAND

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Pembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY

MEMMAT

SELVEDge

A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia

PED-DNX2401

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma